DR. DOUGLAS GAVIN KONDO, M.D.
Psychiatric in Salt Lake City, UT

License number

Utah 6313601-1205

Personal information

See more information about DOUGLAS GAVIN KONDO at radaris.com

Name

Address

Phone

Douglas Kondo

560 Marion St, Salt Lake City, UT 84116

Professional information

See more information about DOUGLAS GAVIN KONDO at trustoria.com

Assistant Professor At University Of Utah School Of Medicine

Position:

Assistant Professor at University of Utah School of Medicine

Location:

Greater Salt Lake City Area

Industry:

Research

Work:

University of Utah School of Medicine - Assistant Professor Duke Clinical Research Institute Jul 2004 - Jan 2007 - Research Fellow Duke University Medical Center Jul 2001 - Jun 2004 - Child Psychiatry Resident The Menninger Clinic Jul 1999 - Jun 2001 - General Psychiatry Resident

Education:

University of Utah School of Medicine 1995 - 1999
M.D., Medicine University of Virginia 1982 - 1986
B.A., Philosophy

Interests:

neuroimaging, child psychiatry, psychopharmacology, clinical trials, genetics, bipolar disorder, major depressive disorder, ADHD, anxiety disorders, cognitive-behavioral-therapy (CBT), adolescent suicide

Honor & Awards:

2003 Presidential Scholar for Research, American Academy of Child & Adolescent Psychiatry NARSAD Young Investigator Award

Dr. Douglas G Kondo, Salt Lake City UT - MD (Doctor of Medicine)

Specialties:

Child & Adolescent Psychiatry

Address:

501 Chipeta Way SUITE 1662, Salt Lake City 84108
(801) 583-2500 (Phone), (801) 585-6363 (Fax)
UNIVERSITY NEUROPSYCHIATRIC INSTITUTE
501 S Chipeta Way, Salt Lake City 84108
(801) 587-3297 (Phone), (801) 587-3303 (Fax)

Certifications:

Child & Adolescent Psychiatry, 2006, Psychiatry, 2005

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
University of Utah
Graduated: 1999
Duke University Med Center
Menninger Clinic

Douglas Gavin Kondo, Salt Lake City UT

Specialties:

Psychiatrist

Address:

50 N Medical Dr, Salt Lake City, UT 84132
501 S Chipeta Way, Salt Lake City, UT 84108

Board certifications:

American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Child and Adolescent Psychiatry (Psychiatry and Neurology)

Douglas G Kondo, Salt Lake City UT

Specialties:

Psychiatry, Child & Adolescent Psychiatry, Child Psychiatry

Work:

University Neuropsychiatric Institute
501 S Chipeta Way, Salt Lake City, UT 84108 The Brain Institute
383 S Colorow Dr, Salt Lake City, UT 84108 Mood Disorders Clinic
30 N Medical Dr, Salt Lake City, UT 84132 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148

Education:

University of Utah (1999)

Depression Disorder Therapeutics With Creatine Analogs

US Patent:

2013032, Dec 5, 2013

Filed:

Oct 7, 2011

Appl. No.:

13/878191

Inventors:

Perry F. Renshaw - Salt Lake City UT, US
Douglas G. Kondo - Salt Lake City UT, US

Assignee:

UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT

International Classification:

A61K 31/195, A61K 45/06

US Classification:

514565

Abstract:

In one aspect, the invention relates to creatine analogs, compositions comprising same, and methods of using same, alone or in combination with other agents, to treat depression disorders and associated maladies. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Brain Phosphorus Spectroscopy In Bipolar Disorder

US Patent:

2013012, May 16, 2013

Filed:

Oct 16, 2012

Appl. No.:

13/653311

Inventors:

University of Utah Research Foundation - Salt Lake City UT, US
Douglas G. KONDO - Salt Lake City UT, US

Assignee:

UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT

International Classification:

A61B 5/055

US Classification:

600410, 514789

Abstract:

Described herein are systems and methods of identifying bipolar disorder in a person. One such method includes acquiring P spectroscopic imaging data from a region of interest in a brain of the person and subsequently analyzing the P spectroscopic imaging data to obtain a signal intensity and a concentration for one or more phosphorus metabolites. A reduced concentration the one or more phosphorus metabolites, such as inorganic phosphate, in the brain can indicate bipolar disorder in the person. Frontal lobe inorganic phosphate concentration in medication-free adolescents can indicate bipolar depression.